Evaluating tofacitinib citrate in the treatment of moderate-to-severe active ulcerative colitis: design, development and positioning of therapy
Vivy Tran,1 Rania M Shammas,2 Jenny S Sauk,1,3 David Padua1,3–41Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 2Department of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 3Tamar and Vatche Manoukian Division of Digesti...
Main Authors: | Tran V, Shammas RM, Sauk JS, Padua D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-05-01
|
Series: | Clinical and Experimental Gastroenterology |
Subjects: | |
Online Access: | https://www.dovepress.com/evaluating-tofacitinib-citrate-in-the-treatment-of-moderate-to-severe--peer-reviewed-article-CEG |
Similar Items
-
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
by: Sara Santos, et al.
Published: (2021-03-01) -
Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study
by: Peter Hoffmann, et al.
Published: (2020-07-01) -
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data
by: Varyani F, et al.
Published: (2019-12-01) -
The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
by: Jung, S.H, et al.
Published: (2022) -
The use of Tofacitinib in the treatment of inflammatory bowel disease
by: E L Nasonov, et al.
Published: (2019-02-01)